Leaflet IFFEZA 125mcg / 5mcg pressurised inhalation suspension

Product code:
W59661001
Quantity:
1
Indicated for:
asthma; chronic obstructive pulmonary disease
Route of administration:
inhalation
Substance:
fluticasone + formoterol (glucocorticoid + beta-2 adrenergic agonist)
ATC
R03AK07 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

Precautions:

Glaucoma warning

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia

Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

The combination of fluticasone and formoterol is used to treat asthma and chronic obstructive pulmonary disease (COPD). Fluticasone is a corticosteroid that reduces airway inflammation, while formoterol is a bronchodilator that relaxes the bronchial muscles, making breathing easier. Together, these substances help prevent asthma attacks and relieve respiratory symptoms.

The medication is administered by inhalation, usually twice a day, as directed by your doctor. It is important to use the inhaler regularly, even if you have no symptoms, to maintain disease control. Do not use this medication for quick relief of acute attacks.

Side effects may include throat irritation, hoarseness, oral infections, or palpitations. Rarely, severe allergic reactions or worsening of respiratory symptoms may occur. If you experience difficulty breathing or facial swelling, seek medical help immediately.

The combination of fluticasone and formoterol is effective in managing asthma and COPD, but correct use and medical monitoring are necessary to prevent complications and ensure treatment effectiveness.

General data about IFFEZA 125mcg / 5mcg

Substance:
fluticasone + formoterol
Date of latest medicines list:
02-10-2013
Product code:
W59661001
Concentration:
125mcg / 5mcg
Pharmaceutical form:
pressurised inhalation suspension
Quantity:
1
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Concentrations available for fluticasone + formoterol

  • 125mcg/5mcg
  • 250mcg/10mcg
  • 50mcg/5mcg